866-997-4948(US-Canada Toll Free)

Accugenomics, Inc. - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Dec 2012

Category :

Surgical Equipment

No. of Pages : 19 Pages


AccuGenomics, Inc. (AccuGenomics) is a US-based diagnostic company that concentrates on developing standardized molecular diagnostic tests utilizing its patented technology in the field of oncology. The company develops gene expression tests that provide genomic data to diagnose, monitor and inform cancer treatment. Its patented proprietary molecular diagnostics tests, the proprietary combination of internal standards offer standardized, quantitative, numerical measurements which enables gene expression based molecular diagnostics tests to be standardized and can be used for therapeutic intervention, monitoring and diagnosis of cancer disease. AccuGenomics is headquartered in Wilmington, North Carolina, the US.

AccuGenomics intends to commercialize and launch its pipeline of standardized genomic tests in high-growth diagnostics market. Currently, it is pursuing FDA approval for its Standardized BCR-ABL reagents.

This report is a source for data, analysis and actionable intelligence on the Accugenomics, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 3

Key Facts 4
Accugenomics, Inc. - Major Products and Services 5
Accugenomics, Inc. Pipeline Products by Equipment Type 6
Accugenomics, Inc. Pipeline Products by Development Stage 8
Accugenomics, Inc. Pipeline Products by Therapy Area 10
BCR-ABL Molecular Diagnostics Test 12
BCR-ABL Molecular Diagnostics Test Product Status 12
BCR-ABL Molecular Diagnostics Test Product Description 12
Lung Cancer Chemoresistance Test - 4 Gene 13
Lung Cancer Chemoresistance Test - 4 Gene Product Status 13
Lung Cancer Chemoresistance Test - 4 Gene Product Description 13
Lung Cancer Diagnostic Test - 3 Gene 14
Lung Cancer Diagnostic Test - 3 Gene Product Status 14
Lung Cancer Diagnostic Test - 3 Gene Product Description 14
Lung Cancer Risk Test - 14 Gene Test 15
Lung Cancer Risk Test - 14 Gene Test Product Status 15
Lung Cancer Risk Test - 14 Gene Test Product Description 15
Accugenomics, Inc. - Key Competitors 16
Accugenomics, Inc. - Key Employees 17
Accugenomics, Inc. - Locations And Subsidiaries 18
Head Office 18

Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Table


Accugenomics, Inc., Key Facts 1
Accugenomics, Inc. Key Pipeline Products by Equipment Type 1
Accugenomics, Inc. Key Pipeline Products by Therapy Area 1
Accugenomics, Inc. Key Pipeline Products by Development Stage 1
Accugenomics, Inc., Key Facts 4
Accugenomics, Inc., Major Products and Services 5
Accugenomics, Inc. Number of Pipeline Products by Equipment Type 6
Accugenomics, Inc. Pipeline Products by Equipment Type 7
Accugenomics, Inc. Number of Pipeline Products by Development Stage 8
Accugenomics, Inc. Pipeline Products by Development Stage 9
Accugenomics, Inc. Number of Pipeline Products by Therapy Area 10
Accugenomics, Inc. Pipeline Products by Therapy Area 11
BCR-ABL Molecular Diagnostics Test - Product Status 12
BCR-ABL Molecular Diagnostics Test - Product Description 12
Lung Cancer Chemoresistance Test - 4 Gene - Product Status 13
Lung Cancer Chemoresistance Test - 4 Gene - Product Description 13
Lung Cancer Diagnostic Test - 3 Gene - Product Status 14
Lung Cancer Diagnostic Test - 3 Gene - Product Description 14
Lung Cancer Risk Test - 14 Gene Test - Product Status 15
Lung Cancer Risk Test - 14 Gene Test - Product Description 15
Accugenomics, Inc., Key Employees 17

List of Chart


Accugenomics, Inc. Pipeline Products by Equipment Type 6
Accugenomics, Inc. Pipeline Products by Development Stage 8
Accugenomics, Inc. Pipeline Products by Therapy Area 10

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *